Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Drug Discovery Today. Technologies|July 2, 2014
An integrated bioinformatics infrastructure essential for advancing pharmacogenomics and personalized medicine in the context of the FDA's Critical Path InitiativeWeida Tong, Stephen C Harris, Hong Fang, et al.
The American Journal of Managed Care|August 7, 2015
Cost-effectiveness of combinatorial pharmacogenomic testing for treatment-resistant major depressive disorder patientsJohn Hornberger, Qianyi Li, Bruce Quinn
Pharmacogenomics|December 24, 2008
Payer perspectives on pharmacogenomics testing and drug developmentRobert S Epstein, Felix W Frueh, Dawn Geren, et al.
Expert Review of Molecular Diagnostics|November 5, 2004
QA/QC: challenges and pitfalls facing the microarray community and regulatory agenciesLeming Shi, Weida Tong, Federico Goodsaid, et al.
Neurobiology of Disease|February 19, 2002
Widely spread butyrylcholinesterase can hydrolyze acetylcholine in the normal and Alzheimer brainMarsel Mesulam, Angela Guillozet, Pamela Shaw, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|December 21, 2007
Qualification of biomarkers for drug development in organ transplantationGilbert J Burckart, Shashi Amur, Federico M Goodsaid, et al.
Pharmacotherapy|July 29, 2008
Pharmacogenomic biomarker information in drug labels approved by the United States food and drug administration: prevalence of related drug useFelix W Frueh, Shashi Amur, Padmaja Mummaneni, et al.
Journal of Alzheimer'S Disease : JAD|April 30, 2003
Conformational changes and truncation of tau protein during tangle evolution in Alzheimer's diseaseFrancisco García-Sierra, Nupur Ghoshal, Bruce Quinn, et al.
Pharmacotherapy|July 27, 2010
Impact of proton pump inhibitors on the effectiveness of clopidogrel after coronary stent placement: the clopidogrel Medco outcomes studyRolf P Kreutz, Eric J Stanek, Ronald Aubert, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 17, 2015
18F-fluoride PET used for treatment monitoring of systemic cancer therapy: results from the National Oncologic PET RegistryBruce E Hillner, Barry A Siegel, Lucy Hanna, et al.
Pageof 5